What happens when clinicians and researchers uncover data that contradict the dogma that all approved vaccines are “safe and effective”?
In Part 1 of this series, I explored the ways that researchers aligned with the vaccine-industrial complex frame “vaccine hesitancy” amongst the public.
This post will focus on the other side of that coin: the challenges faced by clinicians and researchers who uncover data that contradicts the dogma that all vaccines that gain regulatory approval are – say it with me now – “safe and effective”.
Read more:
